Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

More ‘Headline-Grabbing’ Corporate Deals Expected

By Pharmaceutical Processing | July 10, 2014

LONDON (AP) — More “headline-grabbing” acquisitions are likely over the coming year as businesses take advantage of a period of improving economic growth and cheap financing.

That’s the conclusion of business consulting firm EY, which says the value of takeover deals announced in the first half of 2014 struck its highest level since the end of the boom years in 2007.

In its half-yearly update of corporate activity, EY said Thursday that the value of deals rose by 50 percent from the same period the year before, to $1.7 trillion. Not since the global financial crisis first erupted, prompting companies to batten down the hatches, has the value of deals been that high.

For years, big mergers and acquisitions have been notable for their absence as companies stocked up on cash reserves to weather the global economic storms. Pursuing M&A was very much a secondary consideration for boards round the world.

The latest EY figures confirm change is afoot. From the planned $67 billion tie-up between Comcast and Time Warner, and AT&T’s $67 billion deal with DirecTV to Valeant Pharmaceuticals’ $55 billion hostile approach for botox maker Allergan, the last few months have seen a flurry of high-value corporate activity. Facebook even announced its biggest ever acquisition with a proposed $19 billion takeover of WhatsApp.

EY, which sourced data from Dealogic, said the next 6 to 12 months should continue to provide the “ideal window of opportunity” for businesses to pursue more deals. It said high equity valuations, low interest rates and cheap debt, as well as high cash levels built up during the years of retrenchment, have provided a favorable environment for deal-making.

Those favorable conditions may fade as major central banks start raising interest rates as the global recovery gathers pace. In the U.S., expectations are for rates to start rising in 2015, potentially increasing the cost of financing deals.

“Leading companies will look to do smart and strategic M&A before the current deal climate changes, so we can expect more large, headline-grabbing acquisitions to come,” said Pip McCrostie, EY’s global head of M&A.

Though high in value, EY said the number of mergers and acquisitions remains low, with businesses seemingly looking for big, transformative deals.

Most of the M&A deal-making is happening in developed economies, such as the U.S., Britain and France, as executives think they are less risky options now that their economies are growing again. Though U.S. economic growth suffered a big setback in the first quarter due to bad weather, it’s poised to grow relatively strongly over the rest of the year. And the 18-country eurozone is growing consistently, albeit at a modest pace.

“Emerging high-growth and frontier markets will always be attractive in terms of investment, but safe and secure modest growth is attracting the most investment as the global economy moves into a new phase,” said McCrostie.

Related Articles Read More >

Wyzo
Wyzo high-speed pick-and-place sidebot wins design awards
Purdue University
Purdue University launches institute for advanced manufacturing of pharmaceuticals
Sanofi logo
Sanofi introduces its first digital accelerator 
Cambridge Pharma launches with UK plant in Cambridge Research Park

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards